Australia's most trusted
source of pharma news
Posted 19 June 2024 AM
Ternarx, a new Aussie oncology-focused biotech that could help unlock the 'undruggable' has made its debut with Health Minister, Mark Butler, announcing the official launch of the company yesterday.
The Melbourne-based company is a WEHI spinout company borne from the Australian Centre for Targeted Therapeutics (ACTT) in Bundoora, which received a $15 million grant from the Australian government's Medical Research Future Fund (MRFF) Frontier Health and Medical Research initiative in October 2023.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.